G. Mateu Codina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
G. Mateu Codina has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Roberto Sánchez González
Department of Psychiatry, Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, Barcelona, Spain
8 shared publications C. Castillo-Buenaventura
Institut de Neuropsiquiatria i Addiccions / IMIM Hospital del Mar Medical Research Institute, Addiction Program, Barcelona, Spain
5 shared publicationsM. Torrens
5 shared publicationsM. Torrens-Melich
Institut de Neuropsiquiatria i Addiccions / IMIM Hospital del Mar Medical Research Institute, Addiction Program, Barcelona, Spain
5 shared publicationsA. Farre-Martinez
Institut de Neuropsiquiatria i Addiccions / IMIM Hospital del Mar Medical Research Institute, Addiction Program, Barcelona, Spain
4 shared publicationsM. Torrens Melich
4 shared publications
Latest Publications
- 12 February 2019
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 29, S174-S175
Subjects affected by a substance use disorder with or without a comorbid mental disorder: Looking for differential factors
- 12 February 2019
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 29, S174-S175
Subjects affected by a substance use disorder with or without a comorbid mental disorder: Looking for differential factors
- 1 October 2017
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 27, S1068
Homeless and comorbidity of substance use and severe mental disorders: more than a challenge
- 1 October 2017
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 27, S1068
Homeless and comorbidity of substance use and severe mental disorders: more than a challenge
- 1 April 2017
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 41 (S1) , S477-S478
Gender differences in dual bipolar disorder
Introduction: Women with bipolar disorder are more prone to psychiatric co-morbidity as anxiety, substance use disorders, eating disorders and borderline personality disorder. Nevertheless, substance abuse disorders as co-morbidity in bipolarity are higher in males than females.Objectives: To describe differential characteristics of patients admitted to a psychiatric unit referring to gender in a group of patients with bipolar disorder co-morbid with substances disorders (dually diagnosed patients).Methods: Sociodemographic, clinical and administrative data of all patients diagnosed with bipolar admitted to a dual diagnosis during a 3-year period were collected. The psychiatric diagnosis was made according to DSM-IV-R criteria.Results: From the whole sample (n = 66), males (84.8%) were prevalent. Mean age were 37.71 ± 11.7 and mean length of admission was 24.94 ± 17.9 days. Cannabis (34.8%) and cocaine (33.3%) were the most frequent SUD diagnosis and main reasons for admittance were conduct disorder (33.3%) and mania (25.8%).Women showed higher length of admission, higher severity scores at admission and greater reduction in severity scores along hospitalisation. No other clinical or sociodemographic differences were found comparing both groups of patients (Tables 1–4).Conclusions: Women affected by dual bipolar disorder showed higher severity scores at admission but achieved better remission rates during hospitalisation. Table 1 Demographic characteristics of both groups. Table 2 Clinical and functional variables at admission in both groups. Table 3 Historical data about age of drug use in both groups. Table 4 Severity Scores for both groups of study. Disclosure of interest: The authors have not supplied their declaration of competing interest.
- 1 April 2017
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 41 (S1) , S477-S478
Gender differences in dual bipolar disorder
Introduction: Women with bipolar disorder are more prone to psychiatric co-morbidity as anxiety, substance use disorders, eating disorders and borderline personality disorder. Nevertheless, substance abuse disorders as co-morbidity in bipolarity are higher in males than females.Objectives: To describe differential characteristics of patients admitted to a psychiatric unit referring to gender in a group of patients with bipolar disorder co-morbid with substances disorders (dually diagnosed patients).Methods: Sociodemographic, clinical and administrative data of all patients diagnosed with bipolar admitted to a dual diagnosis during a 3-year period were collected. The psychiatric diagnosis was made according to DSM-IV-R criteria.Results: From the whole sample (n = 66), males (84.8%) were prevalent. Mean age were 37.71 ± 11.7 and mean length of admission was 24.94 ± 17.9 days. Cannabis (34.8%) and cocaine (33.3%) were the most frequent SUD diagnosis and main reasons for admittance were conduct disorder (33.3%) and mania (25.8%).Women showed higher length of admission, higher severity scores at admission and greater reduction in severity scores along hospitalisation. No other clinical or sociodemographic differences were found comparing both groups of patients (Tables 1–4).Conclusions: Women affected by dual bipolar disorder showed higher severity scores at admission but achieved better remission rates during hospitalisation. Table 1 Demographic characteristics of both groups. Table 2 Clinical and functional variables at admission in both groups. Table 3 Historical data about age of drug use in both groups. Table 4 Severity Scores for both groups of study. Disclosure of interest: The authors have not supplied their declaration of competing interest.
- Open Access
- 27 May 2016
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 19 (Suppl_1) , 16-17
PM327. High novelty-seeking scores in dual diagnosed patients: a clinical severity marker?
- 27 May 2016
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 19 (Suppl_1) , 16-17
Open AccessPM327. High novelty-seeking scores in dual diagnosed patients: a clinical severity marker?
- 23 March 2016
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 33 (S1) , S147-S148
Descriptive study of hypothyroidism in an acute psychiatric unit in Barcelona
IntroductionBehavioural, psychological and cognitive disturbance have been associated with hypothyroidism, even it has been suggested that this symptoms may remain despite adequate replacement therapy with thyroxine.ObjectiveTo describe prevalence, sociodemographics and clinical features of patients with hypothyroidism in an acute psychiatric unit.AimsTo know about the relation between hypothyroidism and psychiatric symptoms.MethodsData base collection of all patients admitted between 2010 and 2014 in the acute unit of our psychiatric hospital in Barcelona, was analyzed using SPSS program.ResultsIn all 3.1% of the 4536 total patients had hypothyroidism. Among them, 46% were duplicate cases. Mean age was 53 ± 14.27 years. A total of 82.7% were woman. Patients having a TSH lower than 0.30 were 12%, TSH normal were 60.2%, TSH higher than 5 were 27.8%. Most frequent Levothyroxine dosage was: 75 μg (22.1%), 100 μg (19%), 25 μg (12.5%) and 125 μg (12.5%). Diagnosis more frequently associated with hypothyroidism was: Bipolar (26.5%), Schizophrenia (20%), Depression (15.1%), Unspecified psychosis (10%), Personality disorder (10%), Schizoaffective disorder (7.2%), Paranoia 4.3%.ConclusionMost of patients were stable of thyroid condition when had been admitted to our hospital. Hypothyroidism could be a relapse factor, even when treatment is adequate. Affective disorders are more frequently related with hypothyroidism (lithium has to be consider a confounding factor).Disclosure of interestThe authors have not supplied their declaration of competing interest.
- 23 March 2016
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 33 (S1) , S147-S148
Descriptive study of hypothyroidism in an acute psychiatric unit in Barcelona
IntroductionBehavioural, psychological and cognitive disturbance have been associated with hypothyroidism, even it has been suggested that this symptoms may remain despite adequate replacement therapy with thyroxine.ObjectiveTo describe prevalence, sociodemographics and clinical features of patients with hypothyroidism in an acute psychiatric unit.AimsTo know about the relation between hypothyroidism and psychiatric symptoms.MethodsData base collection of all patients admitted between 2010 and 2014 in the acute unit of our psychiatric hospital in Barcelona, was analyzed using SPSS program.ResultsIn all 3.1% of the 4536 total patients had hypothyroidism. Among them, 46% were duplicate cases. Mean age was 53 ± 14.27 years. A total of 82.7% were woman. Patients having a TSH lower than 0.30 were 12%, TSH normal were 60.2%, TSH higher than 5 were 27.8%. Most frequent Levothyroxine dosage was: 75 μg (22.1%), 100 μg (19%), 25 μg (12.5%) and 125 μg (12.5%). Diagnosis more frequently associated with hypothyroidism was: Bipolar (26.5%), Schizophrenia (20%), Depression (15.1%), Unspecified psychosis (10%), Personality disorder (10%), Schizoaffective disorder (7.2%), Paranoia 4.3%.ConclusionMost of patients were stable of thyroid condition when had been admitted to our hospital. Hypothyroidism could be a relapse factor, even when treatment is adequate. Affective disorders are more frequently related with hypothyroidism (lithium has to be consider a confounding factor).Disclosure of interestThe authors have not supplied their declaration of competing interest.
- 23 March 2016
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 33 (S1) , S298-S299
Personality dimensions and drug of choice: A descriptive study using Cloninger's temperament and character inventory revised
Personality dimensions related with drug use are novelty seeking, impulsivity and harm avoidance. Studies predicting drug of choice over personality variables are controversial.ObjectiveTo describe personality profile of drug users in relation to substance of choice.AimsTo know personality dimension differences according to drug used.MethodsCloninger's TCI-R was administered to 218 patients in a dual diagnosis unit.SPSS was applied.ResultsOf the patients, 33.94% had personality disorder. Principal substances used were alcohol, cocaine and cannabis.Most of drug users had normal scores in each dimension. No high scores were found in reward dependence, self-directedness and cooperativeness with any drug.High scores were observed for novelty seeking in 42.9% of timulants users; for arm avoidance in a quarter of cocaine, alcohol and methadone users and for persistence in 18.2% of hypnotics users.Low scores were observed for reward dependence in 45% of heroine and hypnotics users; for persistence in 50% of methadone and 32% of cocaine users; for self-directedness in most of types of drug users and for cooperativeness in up to 50% in heroine, hypnotics, stimulants and cocaine users.Statistical significant differences were observed for cocaine use and high novelty seeking and low cooperation; for non cannabis use and high harm avoidance; for non anfetamine use and low scores in reward dependence; for opiate use and low self-directedness.ConclusionsMost of patients had normal scores in the different dimensions.Presence of comorbid personality disorder led us to consider the results with caution.Disclosure of interestThe authors have not supplied their declaration of competing interest.
- 23 March 2016
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 33 (S1) , S298-S299
Personality dimensions and drug of choice: A descriptive study using Cloninger's temperament and character inventory revised
Personality dimensions related with drug use are novelty seeking, impulsivity and harm avoidance. Studies predicting drug of choice over personality variables are controversial.ObjectiveTo describe personality profile of drug users in relation to substance of choice.AimsTo know personality dimension differences according to drug used.MethodsCloninger's TCI-R was administered to 218 patients in a dual diagnosis unit.SPSS was applied.ResultsOf the patients, 33.94% had personality disorder. Principal substances used were alcohol, cocaine and cannabis.Most of drug users had normal scores in each dimension. No high scores were found in reward dependence, self-directedness and cooperativeness with any drug.High scores were observed for novelty seeking in 42.9% of timulants users; for arm avoidance in a quarter of cocaine, alcohol and methadone users and for persistence in 18.2% of hypnotics users.Low scores were observed for reward dependence in 45% of heroine and hypnotics users; for persistence in 50% of methadone and 32% of cocaine users; for self-directedness in most of types of drug users and for cooperativeness in up to 50% in heroine, hypnotics, stimulants and cocaine users.Statistical significant differences were observed for cocaine use and high novelty seeking and low cooperation; for non cannabis use and high harm avoidance; for non anfetamine use and low scores in reward dependence; for opiate use and low self-directedness.ConclusionsMost of patients had normal scores in the different dimensions.Presence of comorbid personality disorder led us to consider the results with caution.Disclosure of interestThe authors have not supplied their declaration of competing interest.
- 23 March 2016
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 33 (S1) , S539
Tolerability and side effects of an extended-release injectable suspension of aripripazole in a series of inpatients in a dual diagnosis unit
IntroductionThe integrated care in dual diagnosis units involves selecting pharmacological treatment strategies for both substance use disorder and the non-addictive psychiatric disorder. It is recommended to choose drugs with a favorable balance between efficacy/tolerability, an adequate side effects profile and the minimal drug interactions.Objectives and aimsTo evaluate the tolerability and side effects after first administration-first dose of an extended-release injectable suspension of aripiprazole in a group of patients admitted to an acute dual diagnosis unit.MethodsThe study included a series of patients admitted in our unit from May to August 2015 that received the first dose of the aripiprazole preparation (400 mg). Evaluations included different scales for side effects (SAS, ESRS, UKU) and the clinical global impression scale (CGI).ResultsA total of 9 patients were included and evaluated (all men, mean age: 39-years-old). Diagnoses were: bipolar disorder (5/9), schizophrenia (2/9), schizoaffective disorder (1/9) and delusional disorder (1/9) with concomitant substance use disorder (6 cannabis, 2 alcohol, 1 cocaine). All of them without outpatient control and treatment at admission. The results of the clinical scales conclude that none of them had significant side effects, including extrapyramidal, with an improvement in the ICG scale.ConclusionTolerability of extended-release injectable suspension of aripiprazole was good in all cases. In the future, new cases should be included to extend the sample and to evaluate other aspects such as the craving for substances.Disclosure of interestThe authors have not supplied their declaration of competing interest.
- 23 March 2016
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 33 (S1) , S539
Tolerability and side effects of an extended-release injectable suspension of aripripazole in a series of inpatients in a dual diagnosis unit
IntroductionThe integrated care in dual diagnosis units involves selecting pharmacological treatment strategies for both substance use disorder and the non-addictive psychiatric disorder. It is recommended to choose drugs with a favorable balance between efficacy/tolerability, an adequate side effects profile and the minimal drug interactions.Objectives and aimsTo evaluate the tolerability and side effects after first administration-first dose of an extended-release injectable suspension of aripiprazole in a group of patients admitted to an acute dual diagnosis unit.MethodsThe study included a series of patients admitted in our unit from May to August 2015 that received the first dose of the aripiprazole preparation (400 mg). Evaluations included different scales for side effects (SAS, ESRS, UKU) and the clinical global impression scale (CGI).ResultsA total of 9 patients were included and evaluated (all men, mean age: 39-years-old). Diagnoses were: bipolar disorder (5/9), schizophrenia (2/9), schizoaffective disorder (1/9) and delusional disorder (1/9) with concomitant substance use disorder (6 cannabis, 2 alcohol, 1 cocaine). All of them without outpatient control and treatment at admission. The results of the clinical scales conclude that none of them had significant side effects, including extrapyramidal, with an improvement in the ICG scale.ConclusionTolerability of extended-release injectable suspension of aripiprazole was good in all cases. In the future, new cases should be included to extend the sample and to evaluate other aspects such as the craving for substances.Disclosure of interestThe authors have not supplied their declaration of competing interest.
- 23 March 2016
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 33 (S1) , S307-S308
Early alcohol use as prognostic factor for severity in dually diagnosed patients
ObjectivesDescribe the distinguishing characteristics between patients with early onset of alcohol use (EARLY, age < 15) and late onset of alcohol use (LATE, age > 16), both affected of acute non-substance use psychiatric disorders (non-SUD) and any substance use disorder admitted in a dual diagnosis unit.Material and methodsData on demographic, family, and clinical factors were gathered among subjects admitted to our dual diagnosis unit along three years, all of them meeting DSM-IV criteria of any non-substance related Axis I or II disorder and comorbid substance use disorder (SUD). Statistical analysis was performed by using SPSS program.ResultsWe show results of 748 patients (437 of EARLY group and 311 of LATE group). Predominantly male (73,53%) with a mean age of 39,60 ± 9,7 years. Most prevalent non-SUD psychiatric disorders were psychotic disorder (39,97%) and personality disorder (39,30%). In our sample, most common substances of abuse were Alcohol (45,05%) and Cocaine (30,35%). EARLY patients had an earlier first contact all substances as well as an earlier age of problematic consumption of cocaine, alcohol, opioids and nicotine; they also had major prevalence of opioid SUD, sedatives SUD and amphetamines SUD (see Tables 1, 2 and 3).ConclusionsPatients who began earlier their consumptions of alcohol had major prevalence of opioid, sedatives and amphetamine use. They also had earlier consumptions of other substances and earlier problematic consumptions of cocaine, alcohol, opioids and nicotine, what probably means greater severity of drug addiction in the long run.Disclosure of interestThe authors have not supplied their declaration of competing interest.
- 23 March 2016
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 33 (S1) , S307-S308
Early alcohol use as prognostic factor for severity in dually diagnosed patients
ObjectivesDescribe the distinguishing characteristics between patients with early onset of alcohol use (EARLY, age < 15) and late onset of alcohol use (LATE, age > 16), both affected of acute non-substance use psychiatric disorders (non-SUD) and any substance use disorder admitted in a dual diagnosis unit.Material and methodsData on demographic, family, and clinical factors were gathered among subjects admitted to our dual diagnosis unit along three years, all of them meeting DSM-IV criteria of any non-substance related Axis I or II disorder and comorbid substance use disorder (SUD). Statistical analysis was performed by using SPSS program.ResultsWe show results of 748 patients (437 of EARLY group and 311 of LATE group). Predominantly male (73,53%) with a mean age of 39,60 ± 9,7 years. Most prevalent non-SUD psychiatric disorders were psychotic disorder (39,97%) and personality disorder (39,30%). In our sample, most common substances of abuse were Alcohol (45,05%) and Cocaine (30,35%). EARLY patients had an earlier first contact all substances as well as an earlier age of problematic consumption of cocaine, alcohol, opioids and nicotine; they also had major prevalence of opioid SUD, sedatives SUD and amphetamines SUD (see Tables 1, 2 and 3).ConclusionsPatients who began earlier their consumptions of alcohol had major prevalence of opioid, sedatives and amphetamine use. They also had earlier consumptions of other substances and earlier problematic consumptions of cocaine, alcohol, opioids and nicotine, what probably means greater severity of drug addiction in the long run.Disclosure of interestThe authors have not supplied their declaration of competing interest.
- 1 October 2014
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 24, S567
P.3.f.003 Gender differences in psychosis with co-occurring substance use disorder
- 1 October 2014
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 24, S567
P.3.f.003 Gender differences in psychosis with co-occurring substance use disorder
- 1 March 2011
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 26 (S2) , 28
Early onset of alcohol use: a different personality profile?
IntroductionEarly onset of substances use disorders (SUD) has been related to some personality characteristics and a higher prevalence of social, psychiatric and organic problems.ObjetivesTo describe personality differences in early onset of alcohol use (EO, age≤ 15) subjects and late onset of alcohol use (LO, age≥16), both affected of acute non-substance use psychiatric disorders (Non-SUD) and alcohol related substance use disorders (alcohol SUD).MethodsData on sociodemographic and clinical factors were gathered among subjects meeting DSM-IV criteria of alcohol SUD. Psychometric characteristics were explored with TCI-R.ResultsThe whole sample (N = 188; age 36,8 ± 9,2; 71,4% male) showed mainly hallucinations/delusions (37,7%) at admittance and personality disorders (50,3%) as a most prevalent non-SUD. Most common comorbid SUD were alcohol (59,5%).EO subjects (N = 103) had more prevalence of legal problems (51,4% vs. 15,9%), sedatives misuse (73,8% vs. 54,1%), polydrug abuse (2 ± 1,1 vs. 1,6 ± 1,0) and higher score in ASI psychopathology (5,8 ± 1,3 vs. 4,8 ± 1,8). Most frequent dual diagnosis in EO subjects were psychosis+cannabis SUD (8,7%).EO group was characterized by higher impulsiveness (102,9 ± 16,4 vs 97,0 ± 14,5), disorderliness (127,6 ± 19,2 vs. 117,4 ± 21,7), harm avoidance (30,7 ± 4,9 vs. 28 ± 7,6), eagerness of effort (34,7 ± 7,5 vs. 31,6 ± 8,0), ambitious (19,2 ± 4,6 vs. 17,9 ± 3,1), perfectionist (29,8 ± 5,9 vs. 27,8 ± 6,2), responsibility (30,5 ± 6,9 vs. 27,9 ± 7,7), resourcefulness (25,9 ± 6,3 vs. 23,2 ± 6,8), enlightened second nature (17,7 ± 3,9 vs. 13,9 ± 4,6), social acceptance (32,0 ± 5,8 vs. 29,4 ± 7,1) and lower anticipatory worry (71,7 ± 18,5 vs. 79,8 ± 17,9), dependence (54,5 ± 12,4 vs. 59,2 ± 14,9).ConclusionsEO was characterized by higher scores in impulsiveness, disorderliness, and self-directedness and showed more severity on social, psychopathologic and substance problems.
- 1 March 2011
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 26 (S2) , 28
Early onset of alcohol use: a different personality profile?
IntroductionEarly onset of substances use disorders (SUD) has been related to some personality characteristics and a higher prevalence of social, psychiatric and organic problems.ObjetivesTo describe personality differences in early onset of alcohol use (EO, age≤ 15) subjects and late onset of alcohol use (LO, age≥16), both affected of acute non-substance use psychiatric disorders (Non-SUD) and alcohol related substance use disorders (alcohol SUD).MethodsData on sociodemographic and clinical factors were gathered among subjects meeting DSM-IV criteria of alcohol SUD. Psychometric characteristics were explored with TCI-R.ResultsThe whole sample (N = 188; age 36,8 ± 9,2; 71,4% male) showed mainly hallucinations/delusions (37,7%) at admittance and personality disorders (50,3%) as a most prevalent non-SUD. Most common comorbid SUD were alcohol (59,5%).EO subjects (N = 103) had more prevalence of legal problems (51,4% vs. 15,9%), sedatives misuse (73,8% vs. 54,1%), polydrug abuse (2 ± 1,1 vs. 1,6 ± 1,0) and higher score in ASI psychopathology (5,8 ± 1,3 vs. 4,8 ± 1,8). Most frequent dual diagnosis in EO subjects were psychosis+cannabis SUD (8,7%).EO group was characterized by higher impulsiveness (102,9 ± 16,4 vs 97,0 ± 14,5), disorderliness (127,6 ± 19,2 vs. 117,4 ± 21,7), harm avoidance (30,7 ± 4,9 vs. 28 ± 7,6), eagerness of effort (34,7 ± 7,5 vs. 31,6 ± 8,0), ambitious (19,2 ± 4,6 vs. 17,9 ± 3,1), perfectionist (29,8 ± 5,9 vs. 27,8 ± 6,2), responsibility (30,5 ± 6,9 vs. 27,9 ± 7,7), resourcefulness (25,9 ± 6,3 vs. 23,2 ± 6,8), enlightened second nature (17,7 ± 3,9 vs. 13,9 ± 4,6), social acceptance (32,0 ± 5,8 vs. 29,4 ± 7,1) and lower anticipatory worry (71,7 ± 18,5 vs. 79,8 ± 17,9), dependence (54,5 ± 12,4 vs. 59,2 ± 14,9).ConclusionsEO was characterized by higher scores in impulsiveness, disorderliness, and self-directedness and showed more severity on social, psychopathologic and substance problems.